search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Second serosurveillance study in the Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 study.


- candidate number2587
- NTR NumberNTR977
- ISRCTNISRCTN20164309
- Date ISRCTN created27-jun-2007
- date ISRCTN requested11-jun-2007
- Date Registered NTR16-mei-2007
- Secondary IDsN/A 
- Public TitleSecond serosurveillance study in the Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 study.
- Scientific TitleSecond serosurveillance study in the Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 study.
- ACRONYMPIENTER 2
- hypothesisThe age-specific seroprevalence of a cross-section of the Dutch population for the vaccinations used in the Dutch National Immunisation Programme.
- Healt Condition(s) or Problem(s) studiedInfectious diseases, Vaccination, National immunisation program
- Inclusion criteria1. Subject is part of the study sample;
2. Aged 0-79 years old;
3. Has received a personal invitation for the study;
4. Subject has given written informed consent before start of the study.
- Exclusion criteria1 Subject is an employee of the RIVM.
- mec approval receivedyes
- multicenter trialno
- randomisedno
- group[default]
- TypeSingle arm
- Studytypeintervention
- planned startdate 6-feb-2006
- planned closingdate19-jun-2007
- Target number of participants7700
- InterventionsA blood sample and a questionnaire regarding health perception, diseases (including sexually transmitted), vaccination data.
- Primary outcomeThe age-specific seroprevalence (immunity) for diseases included in the National Immunisation Program of the Dutch general population.
- Secondary outcome1. The age-specific seroprevalence against other infectious diseases, in particular those that might be vaccin preventable in the near future and against those diseases with a frequent subclinical course.
2. The age-specific seroprevalence amongst the allochtonous populations (additional sample).
3. The age-specific seroprevalence amongst non-vaccinated orthodox reformed individuals (additional sample).
- TimepointsN/A
- Trial web sitehttp://www.pienterproject.nl
- statusinclusion stopped: follow-up
- CONTACT FOR PUBLIC QUERIESPhD F.R.M Klis, van der
- CONTACT for SCIENTIFIC QUERIESPhD F.R.M Klis, van der
- Sponsor/Initiator National Institute for Public Health and the Environment (RIVM)
- Funding
(Source(s) of Monetary or Material Support)
Dutch Ministry of Health, Welfare and Sport
- PublicationsN/A
- Brief summaryThis study measures the serological effects of the different vaccinations within the National Immunisation Programme in the Netherlands. A cross-section of the Dutch population (n=21000) will be invited to partake in the study. The study consists of a single blood collection. In addition, the participant is asked to fill in data on past vaccinations and diseases in a questionnaire. The results will provide insight into the immune status of the Dutch population and identify potential gaps in the immunity and subpopulations at risk.
- Main changes (audit trail)
- RECORD16-mei-2007 - 1-dec-2009


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl